Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PB) Cost of Revenue (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Cost of Revenue for 10 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 19.46% year-over-year to $8.6 million, compared with a TTM value of $32.6 million through Dec 2025, up 11.51%, and an annual FY2025 reading of $32.6 million, up 11.52% over the prior year.
  • Cost of Revenue was $8.6 million for Q4 2025 at Global Medical REIT, up from $8.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $8.6 million in Q4 2025 and bottomed at $3.3 million in Q2 2021.
  • Average Cost of Revenue over 5 years is $6.5 million, with a median of $7.2 million recorded in 2023.
  • The sharpest move saw Cost of Revenue surged 81.65% in 2022, then dropped 14.65% in 2023.
  • Year by year, Cost of Revenue stood at $4.5 million in 2021, then soared by 57.78% to $7.1 million in 2022, then fell by 14.65% to $6.1 million in 2023, then grew by 18.11% to $7.2 million in 2024, then grew by 19.46% to $8.6 million in 2025.
  • Business Quant data shows Cost of Revenue for GMRE-PB at $8.6 million in Q4 2025, $8.2 million in Q3 2025, and $8.2 million in Q2 2025.